Hollie K. Foust, General Counsel and Corporate Secretary of CONMED Corp (NASDAQ:CNMD), filed a Form 4 on November 6, 2026, disclosing transactions in common stock and restricted stock units dated November 4, 2026.
Key Highlights
- RSU vesting: Foust converted 4,000 restricted stock units into 4,000 shares of common stock at a price of $0 on November 4, 2026, via transaction code M.
- Tax withholding disposal: 1,124 shares were disposed of on the same date at $53.66 per share via transaction code F.
- Remaining holdings: Following the transactions, Foust directly beneficially owned 5,762 shares of common stock.
- RSU balance zeroed: The 4,000 RSUs reported in Table II were fully converted, leaving 0 RSUs beneficially owned after the transaction.
- RSU plan terms: According to the filing, the RSUs were subject to CONMED's 2018 Long-Term Incentive Plan, vesting over two years with 50% after year 1 and 50% after year 2.
- Role: Foust is identified in the filing as an officer serving as General Counsel and Corporate Secretary of CONMED Corporation.
CONMED General Counsel Foust Reports RSU Conversion and Share Disposal
According to the Form 4 filed on November 6, 2026, Hollie K. Foust, General Counsel and Corporate Secretary of CONMED Corp, reported two transactions in the company's common stock on November 4, 2026. The first transaction, coded M, reflects the conversion of 4,000 restricted stock units into 4,000 shares of common stock at a price of $0. This brought Foust's direct beneficial ownership to 6,886 shares following that transaction.
The second transaction, coded F, reflects the disposal of 1,124 shares at a price of $53.66 per share, reducing Foust's direct beneficial ownership to 5,762 shares. Transaction code F is typically used to indicate shares withheld by the issuer for tax purposes upon the vesting of equity awards, as reflected in the filing's table disclosures.
The filing states that each RSU represents "a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation." The RSUs were governed by the company's 2018 Long-Term Incentive Plan, described in the filing as "vesting over two years with 50% vesting after year 1 and 50% vesting after year 2." Following the M-coded transaction, the filing reports 0 RSUs remaining in Foust's beneficial ownership. The Form 4 was signed by Thomas Fistek for Hollie K. Foust by Power of Attorney.
What Was Disclosed
The filing disclosed the vesting of 4,000 RSUs into common stock and the disposal of 1,124 shares at $53.66 each by CONMED's General Counsel on November 4, 2026, leaving a direct beneficial ownership of 5,762 shares of common stock.




Please wait processing your request...